NuVasive traded at $41.74 this Thursday December 8th, increasing $1.71 or 4.27 percent since the previous trading session. Looking back, over the last four weeks, NuVasive gained 11.22 percent. Over the last 12 months, its price fell by 16.39 percent. Looking ahead, we forecast NuVasive to be priced at 38.67 by the end of this quarter and at 35.04 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 380.75 2.96 0.78% 21.96%
Abbott 106.92 2.11 2.01% -20.43%
AtriCure 43.86 0.81 1.88% -37.62%
Baxter International 52.62 0.27 0.52% -34.68%
Becton, Dickinson and Co. 247.97 1.49 0.60% 1.22%
Boston Scientific 46.32 0.69 1.51% 12.21%
Cooper Companies 319.43 4.85 1.54% -21.79%
Cardiovascular Systems 13.43 0.13 0.98% -30.92%
Dexcom 122.67 4.76 4.04% -12.40%
Edwards Lifesciences 72.48 -0.10 -0.14% -39.77%
Globus Medical 71.67 1.61 2.30% 5.43%
Haemonetics 83.72 0.20 0.24% 56.57%
Hologic 74.80 1.00 1.36% -0.52%
Integra LifeSciences 56.50 0.89 1.60% -13.44%
Inogen 21.18 0.22 1.05% -38.68%
Intuitive Surgical 272.02 4.06 1.52% -21.14%
J&J 177.20 0.03 0.02% 6.81%
Medtronic 77.79 0.88 1.14% -30.81%
Merit Medical Systems 73.01 2.04 2.87% 13.56%
NuVasive 41.74 1.71 4.27% -16.39%
Orthofix International 20.87 0.18 0.87% -30.32%
Insulet 303.34 -1.55 -0.51% 12.98%
Stryker 247.84 5.76 2.38% -4.75%
Teleflex 245.13 4.81 2.00% -23.48%
Tandem Diabetes Care 44.27 1.98 4.68% -67.03%
Zimmer Biomet Holdings Inc 125.84 1.65 1.33% 0.32%

Indexes Price Day Year
USND 11082 123.45 1.13% -28.58%
US2000 1818 11.39 0.63% -18.10%
US400 2496 18.65 0.75% -10.13%

NuVasive
NuVasive, Inc. is a developer of specialty spinal implants into a global medical technology company that is delivering integrated solutions for spine surgery. The Company's portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, and intraoperative neuromonitoring technology and service offerings. The Company's surgical access instruments include its Maxcess integrated split-blade retractor system. The Company's neuromonitoring software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support. The Company's Advanced Materials Science portfolio of specialized spinal implants is designed to advance spinal fusion by improving the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone (PEEK).